Omalizumab facilitates rapid oral desensitization for peanut allergy

BACKGROUND: Peanut oral immunotherapy (OIT) is a promising approach to peanut allergy but reactions are frequent and some patients cannot be desensitized. The anti-IgE medication omalizumab (Xolair) may allow more rapid peanut updosing and decrease reactions. OBJECTIVE: To evaluate if omalizumab fac...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Allergy Clin Immunol
Hoofdauteurs: MacGinnitie, Andrew J., Rachid, Rima, Gragg, Hana, Little, Sara V, Lakin, Paul, Cianferoni, Antonella, Heimall, Jennifer, Makhija, Melanie, Robison, Rachel, Chinthrajah, R. Sharon, Lee, John, Lebovidge, Jennifer, Dominguez, Tina, Rooney, Courtney, Lewis, Megan Ott, Koss, Jennifer, Burke-Roberts, Elizabeth, Chin, Kimberly, Logvinenko, Tanya, Pongracic, Jacqueline A., Umetsu, Dale T., Spergel, Jonathan, Nadeau, Kari C., Schneider, Lynda C.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2016
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5369605/
https://ncbi.nlm.nih.gov/pubmed/27609658
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2016.08.010
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items